Type 1 insulin-like growth factor receptor (IGF1R), an oncogene, is considered to be involved in the tumour progression by mediating the ATK signaling pathway; however, the specific mechanism of IGF1R in PCa is unclear (Li et al., 2014; Du et al., 2020b). The gene discussed is IGF1R; the disease is neoplasm.